Kutatási jelek – Signal Engine

• Baseline Gustave Roussy Immune Score and Survival in Extensive-Stage Small-Cell Lung Cancer Treated with First-Line Chemoimmunotherapy — SCLC
• Cancerwise Blog | UT MD Anderson — NSCLC
• Ranpirnase Active in Mesothelioma, Might Improve Survival in Some — Thyroid cancer
• Zocilurtatug Pelitecan Displays Meaningful Responses in Pretreated epNECs — Thyroid cancer
• FDA Clears IND for IBI363 in Squamous Non‑Small Cell Lung Cancer — NSCLC
• BCMA/CD19 CAR T Shows Encouraging Results in R/R Multiple Myeloma | CancerNetwork — Multiple myeloma
• Nanomedicine-Empowered CAR‑T Therapy for Multiple Myeloma: Toward Programmable, Durable, and Precision Immunotherapy — Multiple myeloma
• Adjuvant Atezolizumab/mFOLFOX6 Improves DFS in Stage III dMMR Colon Cancer — Colorectal cancer
• Osteosarcoma Treatment & Management: Approach Considerations, Pharmacologic Treatment, Biopsy — Osteosarcoma
• Advanced Materials for Biologics Delivery to Brain Tumors — Acute lymphoblastic leukemia
• Thyroid Cancer Awareness Month: CCIL Members Making Research Progress — Thyroid cancer
• Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers — NSCLC
• EP. 1: Extensive-Stage Small Cell Lung Cancer Treatment Landscape — SCLC
• A Brief History of Major Events in Oncology — Breast cancer
• RevMed748 2026 RevMed748 2026 — NSCLC
• Serotonin receptor agonist suppresses colorectal cancer — Colorectal cancer
• BCG Treatment for Bladder Cancer: What to Expect — Bladder cancer
• KRAS Biomarker — Colorectal cancer
• Tumor Treating Fields Extend Survival, but Uptake Has Been Slow — Glioblastoma
• Second-Line Utilization and Evolving Options in Advanced Renal Cell Carcinoma — Renal cell carcinoma